Establishes the "Prescription Drug Savings and Transparency Act of 2026" to evaluate consolidated prescription drug management within Medicaid.

The "Prescription Drug Savings and Transparency Act of 2026" mandates an independent study by the office of the auditor general to assess whether Rhode Island would benefit from adopting a consolidated prescription drug management program within the Medicaid program. The study will compare various prescription drug management structures, including administration through managed care organizations, a single statewide preferred drug list, and a single state-contracted pharmacy benefit manager.

Establishes the "Prescription Drug Savings and Transparency Act of 2026" to evaluate consolidated prescription drug management within Medicaid.

The "Prescription Drug Savings and Transparency Act of 2026" mandates an independent study by the office of the auditor general to assess whether Rhode Island would benefit from adopting a consolidated prescription drug management program within the Medicaid program. The study will compare various prescription drug management structures, including administration through managed care organizations, a single statewide preferred drug list, and a single state-contracted pharmacy benefit manager.